Cancer Gene Therapy 2018 Global Market Expected to Grow at CAGR 20.63% and Forecast to 2021

pune India - February 1, 2018 /MarketersMedia/ —

Global Cancer Gene Therapy Market

Description

WiseGuyReports.Com adds” Global Cancer Gene Therapy Market 2017-2021 “Research To Its Database.

Cancer gene therapy is the treatment of cancer through gene therapy. The therapy uses genetically engineered vectors mostly viruses to deliver a gene into the individual's body. It can be used for both the prevention and treatment of disease. The major therapies used for the treatment are oncolytic virotherapy, gene transfer, and gene-induced immunotherapy. The rising prevalence rate of cancer has been a huge challenge for the global economies as the disease leads to high rate of mortality and economic losses.

The analysts forecast the global cancer gene therapy market to grow at a CAGR of 20.63% during the period 2017-2021.

Covered in this report 
The report covers the present scenario and the growth prospects of the global cancer gene therapy market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

 
Get sample Report @  https://www.wiseguyreports.com/sample-request/1751411-global-cancer-gene-therapy-market-2017-2021
 

The market is divided into the following segments based on geography: 
• Americas 
• APAC 
• EMEA

The Global Cancer Gene Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
• Adaptimmune 
• bluebird bio 
• Celgene 
• Shanghai Sunway Biotech 
• Shenzhen SiBiono GeneTech 
• SynerGene Therapeutics

Other prominent vendors 
• Altor BioScience 
• Amgen 
• argenx 
• BioCancell 
• GlaxoSmithKline 
• Merck 
• OncoGenex Pharmaceuticals 
• Transgene

Market driver 
• Rising geriatric population 
• For a full, detailed list, view our report

Market challenge 
• High cost of gene therapy treatment 
• For a full, detailed list, view our report

Market trend 
• Favorable government regulations for gene therapy programs 
• For a full, detailed list, view our report

Key questions answered in this report 
• What will the market size be in 2021 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space?

 
Enquiry About Report @ https://www.wiseguyreports.com/enquiry/1751411-global-cancer-gene-therapy-market-2017-2021
 

Table of Contents -Major Key Points

PART 01: Executive summary 

PART 02: Scope of the report 

PART 03: Research Methodology 

PART 04: Market landscape 
• Market outline 
• Market overview 
• Market size and forecast 
• Five forces analysis 

PART 05: Pipeline analysis 

PART 06: Market segmentation by therapy 
• Oncolytic virotherapy 
• Gene transfer 
• Gene-induced immunotherapy 

PART 07: Geographical segmentation 
• Cancer gene therapy in Americas 
• Cancer gene therapy market in EMEA 
• Cancer gene therapy market in APAC 

PART 08: Decision framework 

PART 09: Drivers and challenges 
• Market drivers 
• Market challenges 

PART 10: Market trends 
• Partnerships and collaborations are changing the market scenario 
• Favorable government regulations for gene therapy programs 

PART 11: Vendor landscape 
• Vendor landscape 

PART 12: Key vendor analysis 
• Adaptimmune 
• bluebird bio 
• Celgene 
• Shanghai Sunway Biotech 
• Shenzhen SiBiono GeneTech 
• SynerGene Therapeutics 
• Other prominent vendors 

………..CONTINUED

 

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WiseGuy Research consultants Pvt Ltd.
Address: Office No. 528/524, Amanora Chambers, Magarpatta Road, Hadapsar Pune, Maharashtra 411028
Phone: +1 (339) 368 6938 (US) +44 208 133 9349 (UK)
Website: http://www.wiseguyreports.com

Release ID: 295219